Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Effects of nanoparticles on lung damage in humans

K. Inoue, H. Takano
European Respiratory Journal 2010 35: 224-225; DOI: 10.1183/09031936.00135609
K. Inoue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Takano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editors:

We read with great interest a recent article in the European Respiratory Journal by Song et al. 1 and we would like to add some questions/comments to their paper. First, we are interested in the (estimated) total weight of the polyacrylate nanoparticles detected in the lungs and/or pleural fluids obtained from the patients. In our in vivo experiments, mice were exposed seven times per week to nanoparticles (carbon black 2 and latex 3) at the weight of 50 μg·time−1·animal−1 (∼83 mg in the human body), and did not die within 6 months thereafter (unpublished observation). Taken together, results from the study in humans by Song et al. 1 and our in vivo studies may provide an important finding regarding difference in susceptibility to nanoparticles between humans and rodents. The second point to be addressed is the possibility of endotoxin attaching to (around) the nanoparticles. Do the authors have any information about endotoxin level in the lung samples or endotoxin concentration in the workplace? We have previously demonstrated that combined exposure to nanoparticles and endotoxin elicited devastating lung injury compared to nanoparticles or endotoxin alone 4. The lethal events occurring in the patients may have resulted from synergistic effects of nanoparticles with other toxic substances, rather than effects of the nanoparticles alone. Finally, we would like to know if these seven patients had pre-existing atopy. In particular, we are interested in the physical condition of the patients described in “The general characteristics of the patients” section in which “all patients suffered from rash with intense itching on their faces” 1, implicating an association with some immunological impairment. Allergen-specific immunoglobulin (Ig)E titres examined by radioallergosorbent test could provide hints for detection, as total IgE (measured by radioimmunosorbent test) does not always cover allergic conditions. Furthermore, atopic subjects are prone to particulate matter (PM), i.e. PM exposure significantly exacerbates the pathophysiology in the subjects 2, 5, sometimes leading to a fatal outcome. A careful search for pre-existing illness (in particular, atopy) may have helped in resolving the pathogenesis of the lung damage seen in the patients. In any case, the study by Song et al. 1 is valuable for future inhalation toxicology, and environmental and preventive medicine, if correlated to previous in vivo findings.

Statement of interest

None declared.

    • © ERS Journals Ltd

    References

    1. ↵
      Song Y, Li X, Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J 2009;34:559–567.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Inoue K, Takano H, Yanagisawa R, et al. Effects of nano particles on antigen-related airway inflammation in mice. Respir Res 2005;6:106
      OpenUrlCrossRefPubMed
    3. ↵
      Inoue K, Takano H, Yanagisawa R, et al. Size effects of latex nanomaterials on lung inflammation in mice. Toxicol Appl Pharmacol 2009;234:68–76.
      OpenUrlCrossRefPubMedWeb of Science
    4. ↵
      Inoue K, Takano H, Yanagisawa R, et al. Effects of airway exposure to nanoparticles on lung inflammation induced by bacterial endotoxin in mice. Environ Health Perspect 2006;114:1325–1330.
      OpenUrlPubMedWeb of Science
    5. ↵
      Dockery DW, Pope CA 3rd, Xu X. et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329:1753–1759.
      OpenUrlCrossRefPubMedWeb of Science
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 35 Issue 1 Table of Contents
    European Respiratory Journal: 35 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Effects of nanoparticles on lung damage in humans
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Effects of nanoparticles on lung damage in humans
    K. Inoue, H. Takano
    European Respiratory Journal Jan 2010, 35 (1) 224-225; DOI: 10.1183/09031936.00135609

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Effects of nanoparticles on lung damage in humans
    K. Inoue, H. Takano
    European Respiratory Journal Jan 2010, 35 (1) 224-225; DOI: 10.1183/09031936.00135609
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Statement of interest
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Clinical outcomes of bronchiectasis in India
    • Reply: Clinical outcomes of bronchiectasis in India
    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society